Effects of palliative intrathecal analgesia on patients with refractory cancer bone pain

被引：0

作者：

Haraga, Isao ^{[1
,2
]}

Kosugi, Toshifumi ^{[3
]}

Sadashima, Eiji ^{[4
]}

Yumiba, Tomoko ^{[3
]}

Kubo, Mayuko ^{[3
]}

Ishikawa-Konishi, Asako ^{[3
,5
]}

Akiyoshi, Kozaburo ^{[1
]}

机构：

[1] Fukuoka Univ, Fac Med, Dept Anesthesiol, 7-45-1 Nanakuma,Jonan Ku, Fukuoka, Fukuoka 8140180, Japan

[2] Kitakyushu Municipal Med Ctr, Dept Anesthesiol, 2-1-1 Bashaku,Kokurakita Ku, Kitakyushu, Fukuoka 8028561, Japan

[3] Saga Ken Med Ctr Koseikan, Dept Palliat Care, 400 Nakabaru, Saga, Saga 8408571, Japan

[4] Saga Ken Med Ctr Koseikan, Med Res Inst, 400Nakabaru, Saga, Saga 8408571, Japan

[5] Tachikawa Home Care Clin, 5-71-16 Saiwai Cho, Tachikawa, Tokyo 1900002, Japan

来源：

JOURNAL OF ANESTHESIA | 2024年 / 38卷 / 03期

关键词：

Palliative care; Cancer pain; Bone Metastasis; Spinal injections; RANDOMIZED CLINICAL-TRIAL; COMPREHENSIVE MEDICAL-MANAGEMENT; UNRESECTABLE PANCREATIC-CANCER; DRUG-RELATED TOXICITY; LONG-TERM; CELIAC PLEXUS; SURVIVAL; SYSTEM; IMPACT; BUPIVACAINE;

D O I：

10.1007/s00540-024-03338-0

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

This study examined the effects of intrathecal analgesia (ITA) using an extracorporeal pump with a subcutaneous port system in cancer patients with bone metastasis. Among the patients who died of cancer with bone metastasis at the palliative care unit of our institution, 11 who received ITA were selected. Changes in pain, opioid doses, the palliative prognostic index (PPI), and Eastern Cooperative Oncology Group Performance Scale-after ITA were assessed. Pain, opioid doses, and PPI decreased after ITA (P = 0.002, 0.002, and 0.017). ITA for cancer patients with increased PPI due to refractory cancer bone pain decreased pain, opioid doses, and PPI.

引用

页码：405 / 411

页数：7

共 50 条

[21] Intrathecal neurolytic block in a patient with refractory cancer pain
Watanabe, Akihiko
Yamakage, Michiaki
JOURNAL OF ANESTHESIA, 2011, 25 (04) : 603 - 605
[22] Intrathecal S(+)-ketamine in refractory neuropathic cancer pain
Kozek, SA
Sator-Katzenschlager, S
Kress, HG
PAIN, 2006, 121 (03) : 283 - 284
[23] Failed intrathecal analgesia following severe, terminal cancer pain
Holmfred, A
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2004, 48 (06) : 796 - 796
[24] Intrathecal neurolytic block in a patient with refractory cancer pain
Akihiko Watanabe
Michiaki Yamakage
Journal of Anesthesia, 2011, 25
[25] Analgesia for pelvic and perineal cancer pain by intrathecal steroid injection
Taguchi, H
Shingu, K
Okuda, H
Matsumoto, H
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2002, 46 (02) : 190 - 193
[26] THE IMPORTANCE OF INTRATHECAL OPIATE ANALGESIA IN THE TREATMENT OF TERMINAL CANCER PAIN
MOTSCH, J
BLESER, W
ISMAILY, AJ
ANASTHESIOLOGIE & INTENSIVMEDIZIN, 1987, 28 (09): : 283 - 287
[27] The role of intrathecal analgesia in palliative care.
Overmeyer, K
Laird, J
ONCOLOGY NURSING FORUM, 2004, 31 (02) : 399 - 399
[28] Intrathecal Analgesia and Palliative Care: A Case Study
Salins, Naveen S.
Crawford, Gregory B.
INDIAN JOURNAL OF PALLIATIVE CARE, 2010, 16 (01) : 44 - 47
[29] Excessive daytime sleepiness in patients on intrathecal analgesia for chronic pain
Demartini, Laura
Fanfulla, Francesco
Bonezzi, Cesare
Armiento, Luciana
Buonocore, Michelangelo
GIORNALE ITALIANO DI MEDICINA DEL LAVORO ED ERGONOMIA, 2015, 37 (04) : 260 - 267
[30] Continuous intracisternal and high cervical intrathecal bupivacaine analgesia in refractory head and neck pain
Appelgren, L
Janson, M
Nitescu, P
Curelaru, L
ANESTHESIOLOGY, 1996, 84 (02) : 256 - 272

← 1 2 3 4 5 →